CREATED BY ELEASYS LLC

Month: May 2020

How could the antiproliferative drug Jakafi help us defeat the SARS-CoV-2 coronavirus?

TeachableMedicalNews article 05072020

Teachable moment in classrooms:

  1. blood chapter – white blood cell types and their functions
  2. blood chapter – hematopoiesis in red bone marrow
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the anti-proliferative drug Jakafi help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the anti-proliferative drug will be evaluated as potential treatment of SARS-CoV-2 infected patients:

Incyte drug could be part of COVID-19 treatment

A global biopharmaceutical company based in Delaware is working to get one of its drugs approved to treat the new coronavirus disease. Officials at Incyte…

The news item mentions that the drug may inhibit cytokine storm in coronavirus infected patients.

How could the drug Opaganib help us defeat the SARS-CoV-2 coronavirus?

TeachableMedicalNews article 05022020

Teachable moment in classrooms:

  1. cellular basis of life chapter – cell cycle and mitosis
  2. blood chapter – white blood cell types and their functions
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the drug Opaganib help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the investigational drug Opaganib will be evaluated as potential treatment of SARS-CoV-2 infected patients:

https://www.timesofisrael.com/2-israeli-covid-19-patients-improve-in-experimental-drug-trial/

The news item mentions that the drug has an anti-inflammatory effect, and that it is a sphingosine kinase inhibitor.

Powered by WordPress & Theme by Anders Norén